Filing Details
- Accession Number:
- 0001104659-16-108205
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-29 11:54:23
- Reporting Period:
- 2016-03-29
- Filing Date:
- 2016-03-29
- Accepted Time:
- 2016-03-29 11:54:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1626971 | Corvus Pharmaceuticals Inc. | CRVS | () | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1193586 | Adams Street Partners Llc | One North Wacker, Suite 2200 Chicago IL 60606 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 Par Value | Acquisiton | 2016-03-29 | 550,864 | $0.00 | 550,864 | No | 4 | C | Indirect | By Fund |
| Common Stock, $0.0001 Par Value | Acquisiton | 2016-03-29 | 92,278 | $0.00 | 643,142 | No | 4 | C | Indirect | By Fund |
| Common Stock, $0.0001 Par Value | Acquisiton | 2016-03-29 | 51,712 | $15.00 | 694,854 | No | 4 | P | Indirect | By Fund |
| Common Stock, $0.0001 Par Value | Acquisiton | 2016-03-29 | 567,121 | $0.00 | 567,121 | No | 4 | C | Indirect | By Fund |
| Common Stock, $0.0001 Par Value | Acquisiton | 2016-03-29 | 95,001 | $0.00 | 662,122 | No | 4 | C | Indirect | By Fund |
| Common Stock, $0.0001 Par Value | Acquisiton | 2016-03-29 | 53,239 | $15.00 | 715,361 | No | 4 | P | Indirect | By Fund |
| Common Stock, $0.0001 Par Value | Acquisiton | 2016-03-29 | 428,998 | $0.00 | 428,998 | No | 4 | C | Indirect | By Fund |
| Common Stock, $0.0001 Par Value | Acquisiton | 2016-03-29 | 71,863 | $0.00 | 500,861 | No | 4 | C | Indirect | By Fund |
| Common Stock, $0.0001 Par Value | Acquisiton | 2016-03-29 | 40,272 | $15.00 | 541,133 | No | 4 | P | Indirect | By Fund |
| Common Stock, $0.0001 Par Value | Acquisiton | 2016-03-29 | 583,510 | $0.00 | 583,510 | No | 4 | C | Indirect | By Fund |
| Common Stock, $0.0001 Par Value | Acquisiton | 2016-03-29 | 97,746 | $0.00 | 681,256 | No | 4 | C | Indirect | By Fund |
| Common Stock, $0.0001 Par Value | Acquisiton | 2016-03-29 | 54,777 | $15.00 | 736,033 | No | 4 | P | Indirect | By Fund |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | By Fund |
| No | 4 | C | Indirect | By Fund |
| No | 4 | P | Indirect | By Fund |
| No | 4 | C | Indirect | By Fund |
| No | 4 | C | Indirect | By Fund |
| No | 4 | P | Indirect | By Fund |
| No | 4 | C | Indirect | By Fund |
| No | 4 | C | Indirect | By Fund |
| No | 4 | P | Indirect | By Fund |
| No | 4 | C | Indirect | By Fund |
| No | 4 | C | Indirect | By Fund |
| No | 4 | P | Indirect | By Fund |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Convertible Preferred Stock | Disposition | 2016-03-29 | 550,864 | $0.00 | 550,864 | $0.00 |
| Common Stock | Series B Convertible Preferred Stock | Disposition | 2016-03-29 | 92,278 | $0.00 | 92,278 | $0.00 |
| Common Stock | Series A Convertible Preferred Stock | Disposition | 2016-03-29 | 567,121 | $0.00 | 567,121 | $0.00 |
| Common Stock | Series B Convertible Preferred Stock | Disposition | 2016-03-29 | 95,001 | $0.00 | 95,001 | $0.00 |
| Common Stock | Series A Convertible Preferred Stock | Disposition | 2016-03-29 | 428,998 | $0.00 | 428,998 | $0.00 |
| Common Stock | Series B Convertible Preferred Stock | Disposition | 2016-03-29 | 71,863 | $0.00 | 71,863 | $0.00 |
| Common Stock | Series A Convertible Preferred Stock | Disposition | 2016-03-29 | 583,510 | $0.00 | 583,510 | $0.00 |
| Common Stock | Series B Convertible Preferred Stock | Disposition | 2016-03-29 | 97,746 | $0.00 | 97,746 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect |
Footnotes
- The Series A Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Issuer's Common Stock, for no additional consideration, on a 1:1 basis at the consummation of Issuer's initial public offering.
- Represents shares held directly by Adams Street 2011 Direct Fund LP ("AS 2011"). Adams Street Partners, LLC, as the managing member of the general partner of the general partner of AS 2011, may be deemed to beneficially own the shares held by AS 2011. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2011. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert disclaim beneficial ownership of the shares held by AS 2011 except to the extent of their pecuniary interest therein.
- Represents shares held directly by Adams Street 2012 Direct Fund LP ("AS 2012"). Adams Street Partners, LLC, as the managing member of the general partner of the general partner of AS 2012, may be deemed to beneficially own the shares held by AS 2012. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2012. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert disclaim beneficial ownership of the shares held by AS 2012 except to the extent of their pecuniary interest therein.
- Represents shares held directly by Adams Street 2013 Direct Fund LP ("AS 2013"). Adams Street Partners, LLC, as the managing member of the general partner of the general partner of AS 2013, may be deemed to beneficially own the shares held by AS 2013. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2013. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert disclaim beneficial ownership of the shares held by AS 2013 except to the extent of their pecuniary interest therein.
- Represents shares held directly by Adams Street 2014 Direct Fund LP ("AS 2014"). Adams Street Partners, LLC, as the managing member of the general partner of the general partner of AS 2014, may be deemed to beneficially own the shares held by AS 2014. Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert, each of whom is a partner of Adams Street Partners, LLC (or a subsidiary thereof), may be deemed to have shared voting and investment power over the shares held by AS 2014. Adams Street Partners, LLC and Thomas S. Bremner, Jeffrey T. Diehl, Elisha P. Gould, Robin Murray, David S. Welsh and Michael R. Zappert disclaim beneficial ownership of the shares held by AS 2014 except to the extent of their pecuniary interest therein.
- The expiration date is not relevant to the conversion of these securities.
- AS 2011, AS 2012, AS 2013 and AS 2014 purchased an aggregate of 200,000 shares of Issuer's common stock in connection with the initial public offering at the offering price of $15.00 per share.
Billionaire Hedge Funds
